Skip Navigation

A Phase II study of Canakinumab in patients with Myelofibrosis Myeloproliferative Neoplasms Research Consortium

Brief Summary

Type:
Leukemias

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT05467800

Study #:
STUDY00149692

Start Date:
Jan 03, 2024

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT05467800

View Complete Trial Details & Eligibility at ClinicalTrials.gov